| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.5 |